Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ImmunityBio (IBRX) Return on Assets: 2015-2025

Historic Return on Assets for ImmunityBio (IBRX) over the last 10 years, with Sep 2025 value amounting to -0.76%.

  • ImmunityBio's Return on Assets rose 70.00% to -0.76% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.76%, marking a year-over-year increase of 70.00%. This contributed to the annual value of -0.93% for FY2024, which is 41.00% up from last year.
  • As of Q3 2025, ImmunityBio's Return on Assets stood at -0.76%, which was up 27.22% from -1.04% recorded in Q2 2025.
  • ImmunityBio's 5-year Return on Assets high stood at -0.76% for Q3 2025, and its period low was -1.49% during Q2 2023.
  • For the 3-year period, ImmunityBio's Return on Assets averaged around -1.23%, with its median value being -1.25% (2023).
  • Its Return on Assets has fluctuated over the past 5 years, first plummeted by 43bps in 2023, then surged by 70bps in 2025.
  • ImmunityBio's Return on Assets (Quarterly) stood at -1.02% in 2021, then decreased by 14bps to -1.17% in 2022, then fell by 8bps to -1.25% in 2023, then increased by 14bps to -1.11% in 2024, then spiked by 70bps to -0.76% in 2025.
  • Its last three reported values are -0.76% in Q3 2025, -1.04% for Q2 2025, and -1.19% during Q1 2025.